EFFECT OF 11C-METHIONINE-POSITRON EMISSION TOMOGRAPHY ON GROSS TUMOR VOLUME DELINEATION IN STEREOTACTIC RADIOTHERAPY OF SKULL BASE MENINGIOMAS

被引:64
|
作者
Astner, Sabrina T. [1 ]
Dobrei-Ciuchendea, Mihaela [1 ]
Essler, Markus [2 ]
Bundschuh, Ralf A. [2 ]
Sai, Heitetsu [1 ]
Schwaiger, Markus [2 ]
Molls, Michael [1 ]
Weber, Wolfgang A. [3 ]
Grosu, Anca-Ligia [4 ]
机构
[1] Tech Univ Munich, Klinikum Rechts Isar, Dept Radiat Oncol, D-81675 Munich, Germany
[2] Tech Univ Munich, Klinikum Rechts Isar, Dept Nucl Med, D-81675 Munich, Germany
[3] Univ Freiburg, Dept Radiat Oncol, Freiburg, Germany
[4] Univ Freiburg, Dept Nucl Med, Freiburg, Germany
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2008年 / 72卷 / 04期
关键词
Meningioma; Positron emission tomography; C-11-methionine; Gross tumor volume; High-precision radiotherapy;
D O I
10.1016/j.ijrobp.2008.02.058
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: To evaluate the effect of trimodal image fusion using computed tomography (CT), magnetic resonance imaging (MRI) and C-11-methionine positron emission tomography (MET-PET) for gross tumor volume delineation in fractionated stereotactic radiotherapy of skull base meningiomas. Patients and Methods: In 32 patients with skull base meningiomas, the gross tumor volume (GTV) was outlined on CT scans fused to contrast-enhanced MRI (GTV-MRI/CT). A second GTV, encompassing the MET-PET positive region only (GTV-PET), was generated. The additional information obtained by MET-PET concerning the GTV delineation was evaluated using the PET/CT/MRI co-registered images. The sizes of the overlapping regions of GTV-MRI/CT and GTV-PET were calculated and the amounts of additional volumes added by the complementing modality determined. Results: The addition of MET-PET was beneficial for GTV delineation in all but 3 patients. MET-PET detected small tumor portions with a mean volume of 1.6 +/- 1.7 cm(3) that were not identified by CT or MRI. The mean percentage of enlargement of the GTV using MET-PET as an additional imaging method was 9.4 % +/- 10.7 %. Conclusions: Our data have demonstrated that integration of MET-PET in radiotherapy planning of skull base meningiomas can influence the GTV, possibly resulting in an increase, as well as in a decrease. (c) 2008 Elsevier Inc.
引用
收藏
页码:1161 / 1167
页数:7
相关论文
共 50 条
  • [1] 11C-methionine PET improves the target volume delineation of meningiomas treated with stereotactic fractionated radiotherapy
    Grosu, Anca-Ligia
    Weber, Wolfgang A.
    Astner, Sabrina T.
    Adam, Markus
    Krause, Bernd J.
    Schwaiger, Markus
    Molls, Michael
    Nieder, Carsten
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2006, 66 (02): : 339 - 344
  • [2] Delineation gross tumor volume based on positron emission tomography images by a numerical approximation method
    Chen, Yangchun
    Chen, Xiangrong
    Li, Fanyong
    Liu Ji-an
    ANNALS OF NUCLEAR MEDICINE, 2014, 28 (10) : 980 - 985
  • [3] Delineation gross tumor volume based on positron emission tomography images by a numerical approximation method
    Yangchun Chen
    Xiangrong Chen
    Fanyong Li
    Liu Ji-an
    Annals of Nuclear Medicine, 2014, 28 : 980 - 985
  • [4] 11C-Methionine uptake in meningiomas after stereotactic radiotherapy
    Jeltema, Hanne-Rinck
    van Dijken, Bart R. J.
    Tamasi, Katalin
    Drost, Gea
    Heesters, Mart A. A. M.
    van der Hoorn, Anouk
    Glaudemans, Andor W. J. M.
    van Dijk, J. Marc C.
    ANNALS OF NUCLEAR MEDICINE, 2024, 38 (08) : 596 - 606
  • [5] Determination of brain tumor recurrence using 11C-methionine positron emission tomography after radiotherapy
    Yamaguchi, Shigeru
    Hirata, Kenji
    Okamoto, Michinari
    Shimosegawa, Eku
    Hatazawa, Jun
    Hirayama, Ryuichi
    Kagawa, Naoki
    Kishima, Haruhiko
    Oriuchi, Noboru
    Fujii, Masazumi
    Kobayashi, Kentaro
    Kobayashi, Hiroyuki
    Terasaka, Shunsuke
    Nishijima, Ken-ichi
    Kuge, Yuji
    Ito, Yoichi M.
    Nishihara, Hiroshi
    Tamaki, Nagara
    Shiga, Tohru
    CANCER SCIENCE, 2021, 112 (10) : 4246 - 4256
  • [6] Clinical characteristics of meningiomas assessed by 11C-methionine and 18F-fluorodeoxyglucose positron-emission tomography
    Arita, Hideyuki
    Kinoshita, Manabu
    Okita, Yoshiko
    Hirayama, Ryuichi
    Watabe, Tadashi
    Ishohashi, Kayako
    Kijima, Noriyuki
    Kagawa, Naoki
    Fujimoto, Yasunori
    Kishima, Haruhiko
    Shimosegawa, Eku
    Hatazawa, Jun
    Hashimoto, Naoya
    Yoshimine, Toshiki
    JOURNAL OF NEURO-ONCOLOGY, 2012, 107 (02) : 379 - 386
  • [7] Clinical characteristics of meningiomas assessed by 11C-methionine and 18F-fluorodeoxyglucose positron-emission tomography
    Hideyuki Arita
    Manabu Kinoshita
    Yoshiko Okita
    Ryuichi Hirayama
    Tadashi Watabe
    Kayako Ishohashi
    Noriyuki Kijima
    Naoki Kagawa
    Yasunori Fujimoto
    Haruhiko Kishima
    Eku Shimosegawa
    Jun Hatazawa
    Naoya Hashimoto
    Toshiki Yoshimine
    Journal of Neuro-Oncology, 2012, 107 : 379 - 386
  • [8] Magnetic resonance imaging, computed tomography, and 68Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy - a case series
    Reinhold Graf
    Michail Plotkin
    Ingo G Steffen
    Reinhard Wurm
    Peter Wust
    Winfried Brenner
    Volker Budach
    Harun Badakhshi
    Head & Face Medicine, 8
  • [9] Magnetic resonance imaging, computed tomography, and 68Ga-DOTATOC positron emission tomography for imaging skull base meningiomas with infracranial extension treated with stereotactic radiotherapy - a case series
    Graf, Reinhold
    Plotkin, Michail
    Steffen, Ingo G.
    Wurm, Reinhard
    Wust, Peter
    Brenner, Winfried
    Budach, Volker
    Badakhshi, Harun
    HEAD & FACE MEDICINE, 2012, 8
  • [10] Role of 11-C-methionine positron emission tomography for the delineation of the tumor volume in pharyngo-laryngeal squamous cell carcinoma: comparison with FDG-PET and CT
    Geets, X
    Daisne, JF
    Gregoire, V
    Hamoir, M
    Lonneux, M
    RADIOTHERAPY AND ONCOLOGY, 2004, 71 (03) : 267 - 273